Cargando…

Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients

Radiolabelled compounds formulated for injection (radiopharmaceuticals), are increasingly being employed in drug development studies. These can be used in tracer amounts for either pharmacokinetic or pharmacodynamic studies. Such radiotracer studies can also be carried out early in man, even prior t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aboagye, E O, Luthra, S K, Brady, F, Poole, K, Anderson, H, Jones, T, Boobis, A, Burtles, S S, Price, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364192/ https://www.ncbi.nlm.nih.gov/pubmed/11953847 http://dx.doi.org/10.1038/sj.bjc.6600212

Ejemplares similares

Novel positron emission tomography radiotracers in brain tumor imaging
por: D’Souza, Maria Mathew, et al.
Publicado: (2011)

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography
por: Slade, Rozanna L., et al.
Publicado: (2016)

Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
por: Hou, Catherine, et al.
Publicado: (2017)

Antibiotic‐Derived Radiotracers for Positron Emission Tomography: Nuclear or “Unclear” Infection Imaging?
por: Gouws, Arno Christiaan, et al.
Publicado: (2022)

In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
por: Barthel, H, et al.
Publicado: (2004)

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production
por: Schopf, Eric, et al.
Publicado: (2018)

Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers
por: Garrow, Adam A., et al.
Publicado: (2020)

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)
por: Gomes, Pedro M. O., et al.
Publicado: (2020)

Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury
por: Kim, Daehee, et al.
Publicado: (2021)

In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
por: Graham, Thomas J. A., et al.
Publicado: (2023)

Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?
por: Christopoulos, Georgios, et al.
Publicado: (2017)

A Novel Substrate Radiotracer for Molecular Imaging of SIRT2 Expression and Activity with Positron Emission Tomography
por: Bonomi, Robin E., et al.
Publicado: (2018)

Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics
por: Newell, D R, et al.
Publicado: (1999)

Radiosynthesis and Evaluation of [(11)C-Carbonyl]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
por: Wilson, Alan A., et al.
Publicado: (2012)

Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with (18)F-GE-180, a Radiotracer for Translocator Protein (TSPO)
por: Hellberg, Sanna, et al.
Publicado: (2018)

Highly specific noninvasive photoacoustic and positron emission tomography of brain plaque with functionalized croconium dye labeled by a radiotracer
por: Liu, Yajing, et al.
Publicado: (2017)

Positron emission tomography imaging for the assessment of mild traumatic brain injury and chronic traumatic encephalopathy: recent advances in radiotracers
por: Huang, Chu-Xin, et al.
Publicado: (2021)

Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging
por: Liu, Cheng, et al.
Publicado: (2021)

Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2020)

Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK
por: Newell, D R, et al.
Publicado: (2003)

The Synthesis and Evaluations of the (68)Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography
por: Li, Xuena, et al.
Publicado: (2016)

Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility
por: Al Faraj, Achraf, et al.
Publicado: (2015)

Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins
por: Bai, Ping, et al.
Publicado: (2020)

Can Gallium-68 Prostate-specific Membrane Antigen Ligand be a Potential Radiotracer for Renal Cortical Positron Emission Tomography Imaging?
por: Sarikaya, Ismet, et al.
Publicado: (2018)

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
por: Morand, Grégoire B., et al.
Publicado: (2023)

Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells
por: Amgheib, Ala, et al.
Publicado: (2022)

Role of positron emission tomography in lung cancer
por: Miles, K. A.
Publicado: (2015)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)

Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2014)

In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope
por: Collingridge, D R, et al.
Publicado: (2003)

Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2020)

Positron Emission Tomography in Breast Cancer
por: Vercher-Conejero, Jose Luis, et al.
Publicado: (2015)

Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring
por: Challapalli, Amarnath, et al.
Publicado: (2016)

High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia
por: Beppu, Takaaki, et al.
Publicado: (2015)

The role of validation in establishing the scientific credibility of predictive toxicology approaches intended for regulatory application
por: Patterson, Eann A., et al.
Publicado: (2021)

Positron emission tomography in the management of lung cancer
por: Kakhki, Vahid Reza Dabbagh
Publicado: (2007)

Positron Emission Tomography Imaging of Macrophages in Cancer
por: Parker, Candace C., et al.
Publicado: (2021)

Cytotoxicity of polymers intended for the extrusion-based additive manufacturing of surgical guides
por: Burkhardt, Felix, et al.
Publicado: (2022)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_frkk6joac6lq1a22630bq2v07j